Exam fundamentals14 min read·25 July 2026

Is PLAB Still Worth It in 2026? The Honest Answer, With the Actual Numbers

Non-prioritised acceptances into UK specialty training fell from 2,168 to 163 in one round after the Medical Training (Prioritisation) Act 2026. What the Act does and doesn't do, the settlement change most PLAB advice has missed, and a segmented decision framework — every figure from NHS England, the BMA and the legislation.

Revising this topic? See where you stand first.10 free AKT questions — no account

If your goal is a UK specialty training post, 2026 changed the arithmetic against you, and you should know the numbers before you spend anything. Non-prioritised acceptances into specialty training fell from 2,168 in 2025 to 163 in 2026 — a 92% collapse in one recruitment round — after the Medical Training (Prioritisation) Act 2026 became law. If your goal is to work as a doctor in the NHS in a non-training post, or you already have UK residency or UK training behind you, PLAB remains a viable and reasonable route.

So the honest answer is: it depends entirely on which of those you are, and the gap between those two answers is now much wider than it was eighteen months ago.

This post gives you the verified figures from NHS England, the BMA and the legislation itself, explains what the Act does and doesn't do, covers the immigration change that most PLAB advice hasn't caught up with, and lays out a decision framework. We sell UKMLA and PLAB 1 preparation, so we have an obvious interest in you sitting the exam. We're going to tell you when it doesn't make sense anyway, because you can check every number here yourself.

What actually changed in 2026
The number that matters
What the Act does not do
The immigration layer nobody's factoring in
The GMC's own signal
Who should still sit PLAB
Who should think much harder
If you're already mid-journey
What this changes about how you prepare
FAQ

1. What actually changed in 2026

The Medical Training (Prioritisation) Act 2026 became law on 5 March 2026, fast-tracked through Parliament as emergency legislation, applying across all four UK nations. Its stated purpose is to restore competition ratios for specialty training programmes to more reasonable levels.

It prioritises certain groups for places on UK medical training programmes.

For the Foundation Programme (FP2026 onwards), the priority group is:

UK medical graduates
Holders of a primary medical qualification from Ireland
Graduates of institutions in Iceland, Liechtenstein, Norway and Switzerland (the EFTA states, reflecting existing international agreements)

For specialty training (CT1/ST1 onwards, starting August 2026), the priority group is those above plus:

Doctors who have completed, or are completing, relevant UK training programmes
Applicants with specified immigration status: British citizens, Commonwealth citizens with right of abode, Irish citizens, holders of Indefinite Leave to Remain, and those with residence-scheme immigration rights

The timing distinction is important. For posts starting in 2026, prioritisation was applied at the offer stage only, because shortlisting was already underway when the Bill was introduced. For training posts starting from 2027 onwards, prioritisation applies at both the shortlisting and the offer stage. That second one is a much harder filter: at the offer stage you at least reach interview and are assessed. At shortlisting, if there are enough priority candidates, a non-prioritised application may not be looked at.

One detail catches people out, so read it twice: the Foundation Programme priority group is defined by where you qualified, not by your citizenship. A British citizen who studied medicine outside the UK, Ireland or the EFTA states is not in the Foundation Programme priority group. Nationality alone doesn't help you there.

Sources you can check directly: the Act at legislation.gov.uk, NHS England's guidance for applicants to medical training, the House of Commons Library briefing on the Bill, and the BMA's explainer on what the law means for UK graduate prioritisation.

2. The number that matters

NHS England published the impact data in June 2026. For the 2026 specialty training round:

33,953 applications met the required appointable level, for 9,520 specialty training posts.
The overall competition ratio was 4 to 1, which halved to 2 to 1 for prioritised candidates.
19,706 applications were from prioritised candidates.
98% of posts were filled by priority candidates, compared with 72% in 2025.
Non-prioritised acceptances fell from 2,168 to 163.
GP training reached 100% fill by UK graduates or NHS-experienced applicants, against 62% previously.

One honest caveat on those figures: each candidate can make up to five applications, so application counts are not counts of individual doctors. The competition ratios are application-based and will overstate the number of humans involved. NHS England says so themselves.

But the 2,168 → 163 figure is acceptances, not applications. That's real people taking real posts, and it fell by more than nine tenths in a single year. If your plan was "sit PLAB, then compete for a training number", that plan encountered a step change rather than a gradual tightening.

For context on how the pressure built, the Royal College of Physicians has documented the trend in Internal Medicine Training: applications outstripped available posts by 30% in 2019, rising to 73% by 2024, with the applications-per-post figure going from around 1.4 to 3.7 over the same period. And in 2022, 75% of those who completed foundation training in the NHS did not immediately enter core or specialty training. The squeeze predates the Act; the Act redistributed who absorbs it.

The RCP is also explicit that IMGs are an essential part of the NHS workforce, and has warned against solving the domestic recruitment problem by undermining IMG career development. Worth knowing that the professional bodies are not uniformly comfortable with where this landed.

3. What the Act does not do

Precision matters here, because a lot of commentary has overshot.

It does not ban IMGs from applying. Non-prioritised candidates remain eligible. They are considered after the priority group. In 2026, 163 of them were appointed.

It does not touch non-training posts. Trust grade, clinical fellow, locally employed doctor, LAS and SAS roles are not specialty training programmes and are not covered by the Act. This is the single most important thing to understand about your realistic options: the NHS still employs large numbers of doctors outside training programmes, and that is where most IMGs have always started.

It does not close the door permanently. Completing relevant UK training brings you into the specialty training priority group. So the pathway hasn't been removed so much as reordered: UK experience first, training number second. That is a longer and less certain route than the one described in most PLAB guidance written before March 2026, but it is a route.

It is not fixed. The Secretary of State can adjust the prioritised groups by regulation in response to application trends, and the regulations for 2027 onwards will define the priority groups more precisely. Anyone telling you confidently what specialty recruitment looks like in 2029 is guessing.

There is no standalone priority group for refugee doctors. Refugee status alone does not confer prioritisation unless other criteria are met.

4. The immigration layer nobody's factoring in

This is where the PLAB advice online is most out of date, and it interacts with the Act in a way that's easy to miss.

Look again at the specialty training priority group: it includes holders of Indefinite Leave to Remain. So ILR is one of the routes into priority status.

Now the other half. The Government has confirmed plans for an "earned settlement" system that would raise the standard qualifying period for ILR from five years to ten, with implementation expected in autumn 2026. As things stand the five-year route still applies, and transitional arrangements for people already in the UK on a path to settlement have not been finalised — the stated intention is that the change would apply to people already here who have not yet received ILR. Some routes are indicated to keep shorter periods.

We are deliberately hedging that paragraph because the position is genuinely unsettled, and you should not make a decade-long decision on a blog's summary. Read the House of Commons Library briefing on the changes following the 2025 immigration white paper, and take immigration advice.

But note the interaction: if ILR is a route into training priority, and the qualifying period for ILR roughly doubles, then the timeline from arriving in the UK to being a prioritised specialty applicant stretches accordingly. Two separate policy changes, pointing the same way.

Also relevant if you're modelling the move: the Skilled Worker general salary threshold has risen (health and care roles follow NHS Agenda for Change scales rather than the general threshold), the required skill level is now graduate-equivalent, English language requirement is B2 rather than B1, and since April 2026 the Home Office checks salary compliance across individual payroll periods rather than annual totals. Get current figures from a regulated adviser rather than from us.

5. The GMC's own signal

Here's a data point people miss because it looks like administrative trivia.

From February 2027 the GMC is closing PLAB 1 in Dhaka, Alexandria, Accra and Chennai, and cutting international sittings from four a year to three. The GMC's own framing for this is declining demand.

That is the regulator telling you, in its capacity as the body that counts the candidates, that fewer people are sitting this exam. Whatever you conclude about whether the route is worth it, you're not the only person doing the arithmetic. It also has a practical consequence for anyone still going: fewer sittings and fewer centres means a failed attempt costs more in months and in travel than it used to. We cover the operational detail in PLAB 1 in 2027.

6. Who should still sit PLAB

Segment honestly. For these people the route still makes sense:

You want to practise medicine in the NHS, not necessarily to enter specialty training soon. Non-training posts aren't covered by the Act, and clinical fellow, trust grade and LAS roles remain a genuine way to work as a doctor in the UK. Many doctors build good careers in and around these roles, and the SAS route is a recognised career grade rather than a consolation prize.

You already hold a qualifying immigration status. British citizen, Irish citizen, Commonwealth citizen with right of abode, ILR holder, residence-scheme rights — you're in the specialty training priority group. The Act's headline concern largely isn't about you. Note the Foundation Programme caveat in section 1 if you qualified abroad.

You already have or are completing relevant UK training. Same reasoning: you're inside the priority group for specialty recruitment.

You're partway through and the sunk costs are real. If you've passed IELTS or OET, paid fees, and done months of preparation, finishing PLAB 1 is usually rational. The question then becomes what you do with registration, not whether to get it.

Your alternative is worse. This is the comparison that actually matters and it's the one internet advice never makes, because it can't know your situation. "The UK got harder" is only decision-relevant next to a specific alternative. For many doctors the realistic options are a domestic system with its own severe bottlenecks, a US route requiring years and considerably more money, or Australia's AMC pathway. Harder than it was is not the same as worse than everything else.

7. Who should think much harder

Your only goal is a UK specialty training number, starting soon, and you have no qualifying status and no UK experience. Look at 163 acceptances and at prioritisation moving to the shortlisting stage from 2027, and model it honestly. It isn't impossible. It is a materially different proposition from what you were probably told.

You're financing this on debt or family money with no margin. Add it up properly — GMC exam fees for both parts, an English test, travel, possibly UK accommodation for PLAB 2, visa and health surcharge, plus preparation. Then factor in that the first job may be a non-training post, and that settlement timelines may lengthen. If a single failed attempt breaks the plan, the plan is too tight, especially with fewer sittings from 2027.

You're relying on advice written before March 2026. Almost everything published before then describes a different system. Check the date on anything you're using, including this post.

You're choosing the UK primarily because "PLAB is the easy one". It was historically the cheaper and faster licensing route, and that comparison is still often true at the exam stage. It's much less true of what happens after the exam, which is the part that determines whether the investment pays.

8. If you're already mid-journey

Practical, not philosophical:

Finish PLAB 1 if you're close. It's the cheapest component and a pass has a long shelf life. Don't abandon a nearly-complete exam over policy news.
Re-plan the destination, not the exam. Target realistic first posts — clinical fellow, trust grade, LAS — rather than assuming a training number follows registration.
Treat UK experience as the strategic asset it now is. Relevant UK training brings you into the specialty priority group. That reframes a non-training post from a detour into the actual path.
Get immigration advice specific to you, especially on settlement timelines. This is the variable with the longest tail and the least reliable internet commentary.
Watch the 2027 regulations. They will define priority groups more precisely, and prioritisation moves to shortlisting. That's the next thing that will move your odds either way.
Don't fail an attempt you could have passed. With three international sittings a year from 2027 and four closed centres, the cost of a resit is rising in time as much as money.

Our UKMLA for IMGs guide covers the registration mechanics, and UKFP 2027 covers how prioritisation lands on the Foundation Programme application specifically.

9. What this changes about how you prepare

One genuine consequence, and it's the only place in this post where our commercial interest and your interest clearly coincide — judge it accordingly.

Passing first time matters more than it did. Not for the usual motivational reasons. Because the cost of not passing went up: fewer sittings, fewer centres, a longer wait, another fee, and a settlement clock that may be lengthening while you wait. The margin for a casual attempt has narrowed.

In practice that means the things that were always true are now less optional:

Prepare on the current content map. PLAB 1 has run on the GMC's MLA content map since 8 August 2024, and an updated map applies to all MLA exams from September 2026. Material built for the old blueprint is preparing you for a retired exam. See what changed and the checklist version.
Drop the recall strategy. It has been degrading since the map changed, and it produces practice scores that don't predict real performance. Why recalls stopped working.
Rehearse under time. 180 questions in 3 hours. Timing failure is preventable and common. Free mock options.
Close the UK-pathway gap deliberately. The commonest pattern among clinically strong IMGs is right medicine, wrong NHS first-line. NICE guidelines for the UKMLA.

If you're choosing where to prepare, our PLAB 1 question bank comparison covers the options honestly, including where competitors beat us.

10. FAQ

Is PLAB still worth it in 2026? For NHS work in non-training posts, or if you hold a qualifying immigration status or UK training: yes, reasonably. For an early specialty training number with no qualifying status and no UK experience: much harder, and you should look at the 163 figure before committing money.

Can IMGs still get specialty training in the UK? Yes — 163 non-prioritised acceptances in 2026. Not zero, but down from 2,168 the year before, and from 2027 prioritisation applies at shortlisting as well as offer.

Does the Act ban IMGs? No. It orders consideration: the priority group first, then everyone else. IMGs remain eligible to apply.

Are non-training NHS jobs affected? Not by this Act. Trust grade, clinical fellow, LAS and SAS roles are not specialty training programmes.

Can I get into the priority group? Some can. Qualifying immigration statuses include British and Irish citizenship, Commonwealth citizenship with right of abode, ILR, and residence-scheme rights. Completing relevant UK training also brings you into the specialty training priority group. Note the Foundation Programme group is defined by where you qualified, not citizenship.

I'm a British citizen who studied medicine abroad — am I prioritised? For specialty training, British citizenship is among the specified immigration statuses. For the Foundation Programme, the priority group is defined by qualifying in the UK, Ireland or the EFTA states — so a UK citizen with an international degree isn't in that group. Check both against your own case.

Is it true ILR now takes ten years? Not yet. The Government has confirmed plans for an earned-settlement system raising the standard qualifying period from five to ten years, expected autumn 2026, with transitional arrangements not finalised. Take regulated immigration advice rather than relying on any blog, including this one.

Should I do USMLE instead? Different trade, not a straight upgrade: more expensive, longer, and residency is compulsory to practise. The UK's advantage was always speed and cost to licensing, and at the exam stage that's largely intact. What changed is what follows the exam. Compare against your real alternatives, including staying.

Why is the GMC closing exam centres? The GMC attributes it to declining demand, closing PLAB 1 in Dhaka, Alexandria, Accra and Chennai from February 2027 and reducing international sittings from four a year to three.

Where do I check all this myself? legislation.gov.uk for the Act; NHS England for applicant guidance and the June 2026 impact data; the House of Commons Library for briefings on the Bill and on settlement changes; the BMA for the practitioner-facing explainer; gmc-uk.org for exam logistics. Every figure in this post comes from those.

The summary: 2026 didn't close the UK to international doctors, but it did decouple two things that used to travel together — getting registered, and getting trained. Registration through PLAB is much as it was. Progression into specialty training, for a doctor with no qualifying status and no UK experience, is now a substantially harder proposition, and 2027 tightens it further.

Decide against your actual alternatives rather than against how things were in 2023. And if you do go, go prepared enough to pass first time, because the cost of a second attempt is rising in every currency that matters.